BW
MCRB icon

Bison Wealth’s Seres Therapeutics MCRB Stock Holding History

Bison Wealth’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-674
Closed -$64K – 381
2020
Q2 		$64K Hold
674
– – 0.04% 240
2020
Q1 		$48K Sell
674
-589
-47% -$39.5K 0.03% 237
2019
Q4 		$87K Buy
1,263
+18
+1% +$1.33K 0.04% 275
2019
Q3 		$100K Buy
1,245
+100
+9% +$6.61K 0.06% 228
2019
Q2 		$74K Sell
1,145
-375
-25% -$35.6K 0.04% 231
2019
Q1 		$209K Sell
1,520
-136
-8% -$16.6K 0.13% 200
2018
Q4 		$150K Sell
1,656
-132
-7% -$18.5K 0.11% 195
2018
Q3 		$271K Sell
1,788
-150
-8% -$24.3K 0.18% 166
2018
Q2 		$333K Buy
1,938
+242
+14% +$39.5K 0.25% 125
2018
Q1 		$249K Sell
1,696
-12
-0.7% -$2.3K 0.19% 155
2017
Q4 		$346K Buy
+1,708
New +$351K 0.25% 109

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bison Wealth's MCRB Position: Q3 2020 in Review

Bison Wealth sold out of Seres Therapeutics (MCRB) in Q3 2020, closing a stake of 674 shares — an estimated $64K sold.

Bison Wealth first reported a position in MCRB in Q4 2017 and held it in 11 quarters. The position peaked at $346K in Q4 2017. 113 funds tracked by Wall St. Rank hold MCRB as of Q3 2020.

  • Bison Wealth reported no remaining Seres Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Bison Wealth sold 674 Seres Therapeutics shares in Q3 2020, an estimated $64K.
  • Bison Wealth first reported a position in Seres Therapeutics in Q4 2017 and held it in 11 quarters.
  • Bison Wealth's Seres Therapeutics position peaked at $346K in Q4 2017.
  • 113 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2020.

Based on Bison Wealth's 13F filing for Q3 2020, filed 16 Oct 2020.